BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/29/2026 8:41:43 AM | Browse: 2 | Download: 19
 |
Received |
|
2025-10-09 02:50 |
|
Peer-Review Started |
|
2025-10-09 02:50 |
|
First Decision by Editorial Office Director |
|
2025-11-30 01:41 |
|
Return for Revision |
|
2025-11-30 01:41 |
|
Revised |
|
2025-12-11 17:26 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-01-19 02:39 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-01-19 09:55 |
|
Articles in Press |
|
2026-01-19 09:55 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-05-18 04:08 |
|
Publish the Manuscript Online |
|
2026-05-29 08:41 |
| ISSN |
2220-3230 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Editorial |
| Article Title |
Rethinking CKD Risk After Liver Transplantation
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Concetto Sessa, Guido Gembillo and Walter Morale |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Concetto Sessa, MD, Department of Nephrology and Dialysis, Maggiore “Nino Baglieri” Hospital, Via Aldo Moro 1, Modica 97015, Sicily, Italy. concettosessa@gmail.com |
| Key Words |
Liver transplantation; Chronic kidney disease; Calcineurin inhibitors; Tacrolimus; Immunosuppression; Acute kidney injury; Renal protection |
| Core Tip |
CKD after liver transplantation is a modifiable determinant of survival. Beyond CNI toxicity, pre-transplant renal dysfunction, perioperative AKI, and metabolic comorbidities drive risk. Early nephroprotective strategies and tailored immunosuppression are essential to improve outcomes. Proactive perioperative management, delaying CNI exposure, mycophenolate-based CNI minimization, and aggressive metabolic control, significantly improves long-term renal preservation. |
| Publish Date |
2026-05-29 08:41 |
| Citation |
Sessa C, Gembillo G, Morale W. Rethinking CKD Risk After Liver Transplantation. World J Transplant 2026; 16(2): 115035 |
| URL |
https://www.wjgnet.com/2220-3230/full/v16/i2/115035.htm |
| DOI |
https://dx.doi.org/10.5500/wjt.v16.i2.115035 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
